AVH 1.68% $3.02 avita medical inc.

wall street journal avita to dominate

  1. 10,009 Posts.
    http://online.wsj.com/article/PR-CO-20130805-904476.html?mod=googlenews_wsj

    Avita Medical Ltd Expected to Dominate Market for Burns and Scalds Treatment, Says Zacks Analyst via Interview With The Life Sciences Report

    SAN FRANCISCO, CA--(Marketwired - Aug 5, 2013) - Jason Napodano, Senior Biotechnology Analyst at Zacks Investment Research, stated in an interview with George Mack of The Life Sciences Report, "Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) has a regenerative medicine device product called ReCell(R) Spray-On Skin(R) (autologous cell suspension), a treatment for severe skin defects, burns, scalds, scars, vitiligo (discoloration of ...
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.